GR, O., N, D., SC, G., SS, G., PR, P., DD, R., & AR, P. (2022). Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions. Drug safety, 45(6), 601. https://doi.org/10.1007/s40264-022-01182-3
Chicago Style (17th ed.) CitationGR, Onzi, D'Agustini N, Garcia SC, Guterres SS, Pohlmann PR, Rosa DD, and Pohlmann AR. "Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions." Drug Safety 45, no. 6 (2022): 601. https://doi.org/10.1007/s40264-022-01182-3.
MLA (9th ed.) CitationGR, Onzi, et al. "Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions." Drug Safety, vol. 45, no. 6, 2022, p. 601, https://doi.org/10.1007/s40264-022-01182-3.
Warning: These citations may not always be 100% accurate.